Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-01-06

Clinical Trial Update: Comparative Study to Evaluate the Efficacy and Safety of the Fixed-dose Combination of Estradiol / Dydrogesterone in Perimenopausal Women [Phase 4]

View source ↗

Summary

A phase 4 clinical trial evaluating the efficacy and safety of a fixed-dose combination of estradiol and dydrogesterone in perimenopausal women with hot flashes…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Estradiol / Dydrogesterone fixed-dose combination (estradiol/dydrogesterone)

Snippet

Sponsor: Scientific Research Institute of Public Health, Russian Federation | Conditions: Perimenopausal Disorder, Hot Flashes | Phase 4 | Status: UNKNOWN